Abstract | OBJECTIVES: METHODS: Patients (n = 34, mean age = 71.8 + 7.12) with Binswanger type subcortical vascular dementia from 8 multicenter, according to clinical and neuroradiological working criteria, were selected to receive donepezil 5 mg/day (n = 2) or donepezil 10 mg/day (n = 32, after 5 mg/day) for 24 weeks. Our primary endpoints were change from baseline to weeks 12 and 24 in the Seoul Neuropsychological Screening Battery- Dementia version (SNSB-D) and the Korean version of neuropsychiatric inventory (K-NPI). RESULTS: A total of 24 patients received donepezil completed the study (mean age = 72.0 + 7.5 K-Mini-Mental State Examination [MMSE] = 21.0 + 5.1). After 12 weeks and 24 weeks, patients showed improvements in cognitive function on the SNSB-D compared baseline of 16.29 points at 12 weeks (P < .05) and 12.44 points at 24 weeks (P < .05). Significant improvements were shown in only memory domain, immediate verbal recall and delayed recall tests. Subgroup with better cognitive function (SNSB-D > 100) were more effective in frontal and memory domains than the other subgroup (SNSB-D < 100). Withdrawal rates due to adverse events were very low (4.16%). CONCLUSIONS:
|
Authors | Jay Cheol Kwon, Eung Gyu Kim, Jae Woo Kim, Oh Dae Kwon, Bong Goo Yoo, Hyon Ah Yi, Nack Cheon Choi, Seon Young Ahn, Byung Hwa Lee, Myong Jin Kang, Dae Seob Choi, BKVD Study Group |
Journal | American journal of Alzheimer's disease and other dementias
(Am J Alzheimers Dis Other Demen)
2009 Aug-Sep
Vol. 24
Issue 4
Pg. 293-301
ISSN: 1938-2731 [Electronic] United States |
PMID | 19383979
(Publication Type: Clinical Trial, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Indans
- Nootropic Agents
- Piperidines
- Donepezil
|
Topics |
- Aged
- Aged, 80 and over
- Cognition
(drug effects)
- Cognition Disorders
(drug therapy, pathology)
- Dementia, Vascular
(drug therapy, pathology)
- Donepezil
- Female
- Follow-Up Studies
- Humans
- Indans
(administration & dosage, adverse effects)
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Nootropic Agents
(administration & dosage, adverse effects)
- Piperidines
(administration & dosage, adverse effects)
- Treatment Outcome
|